12:21 PM EDT, 08/08/2024 (MT Newswires) -- AxoGen ( AXGN ) said Thursday that it appointed Michael Dale as chief executive, effective Friday.

Dale succeeds Karen Zaderej who will remain with AxoGen ( AXGN ) in an advisory role for nine months, according to the company.

Dale's past executive leadership roles span both public and private medical device companies, the firm said.

Board member Paul Thomas will become the new chairman of the board, effective Friday, AxoGen ( AXGN ) added.

Price: 10.46, Change: +2.54, Percent Change: +32.01